Status and trends in epidemiologic characteristics of diabetic end-stage renal disease: an analysis of the 2021 Korean Renal Data System

被引:2
|
作者
Kim, Kyeong Min [1 ]
Jeong, Seon A. [2 ]
Ban, Tae Hyun [3 ]
Hong, Yu Ah [4 ]
Hwang, Seun Deuk [5 ]
Choi, Sun Ryoung [6 ]
Lee, Hajeong [7 ]
Kim, Ji Hyun [8 ]
Kim, Su Hyun [9 ]
Kim, Tae Hee [10 ]
Koo, Ho-Seok [11 ,18 ]
Yoon, Chang-Yun [12 ]
Kim, Kiwon [13 ]
Ahn, Seon Ho [14 ]
Kim, Yong Kyun [15 ,16 ]
Yoon, Hye Eun [17 ,19 ]
机构
[1] Eulji Univ, Coll Med, Dept Internal Med, Daejeon Eulji Med Ctr, Daejeon, South Korea
[2] Korean Soc Nephrol, Seoul, South Korea
[3] Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
[4] Catholic Univ Korea, Daejeon St Marys Hosp, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Inha Univ, Coll Med, Dept Internal Med, Incheon, South Korea
[6] Samyook Med Ctr, Dept Internal Med, Seoul, South Korea
[7] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Dept Pediat, Seongnam, South Korea
[9] Chung Ang Univ, Gwangmyeong Hosp, Coll Med, Dept Internal Med, Gwangmyeong, South Korea
[10] Inje Univ, Coll Med, Busan Paik Hosp, Dept Internal Med, Busan, South Korea
[11] Inje Univ, Coll Med, Seoul Paik Hosp, Dept Internal Med, Seoul, South Korea
[12] Yoons Med Clin, Dialysis Ctr, Seoul, South Korea
[13] Seoul One Clin, Anyang, South Korea
[14] Wonkwang Univ, Wonkwang Univ Hosp, Sch Med, Dept Internal Med, Iksan, South Korea
[15] Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
[16] Catholic Univ Korea, Cell Death Dis Res Ctr, Coll Med, Seoul, South Korea
[17] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Internal Med, Seoul, South Korea
[18] Seoul K Clinc, Seoul, South Korea
[19] Catholic Univ Korea, Incheon St Marys Hosp, Coll Med, Dept Internal Med, 56 Dongsu Ro, Incheon 21431, South Korea
关键词
Chronic renal insufficiency; Diabetes mellitus; Dialysis; Chronic kidney failure; Mortality; PERITONEAL-DIALYSIS; REPLACEMENT THERAPY; KIDNEY-DISEASE; HEMODIALYSIS; MORTALITY; MODALITY;
D O I
10.23876/j.krcp.23.130
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Korean Renal Data System (KORDS) is a nationwide end-stage renal disease (ESRD) registry database operated by the Korean Society of Nephrology (KSN). Diabetes mellitus is currently the leading cause of ESRD in Korea; this article provides an update on the trends and characteristics of diabetic ESRD patients. The KORDS Committee of KSN collects data on dialysis centers and patients through an online registry program. Here, we analyzed the status and trends in characteristics of diabetic chronic kidney disease stage 5D (CKD 5D) patients using data from 2001 to 2021. In 2021, the dialysis adequacy of hemodialysis (HD) was lower in diabetic CKD 5D patients than in nondiabetic CKD 5D patients, while that of peritoneal dialysis (PD) was similar. Diabetic CKD 5D patients had a higher proportion of cardiac and vascular diseases and were more frequently admitted to hospitals than nondiabetic CKD 5D patients, and the leading cause of death was cardiac disease. From 2001 to 2020, diabetic CKD 5D patients had a higher mortality rate than nondiabetic CKD 5D patients, but in 2021 this trend was reversed. Diabetic PD patients had the highest mortality rate over 20 years. The mortality rate of diabetic HD patients was higher than that of nondiabetic HD patients until 2019 but became lower starting in 2020. There was a decreasing trend in mortality rate in diabetic CKD 5D patients, but cardiac and vascular diseases were still prevalent in diabetic CKD 5D patients with frequent admissions to hospitals. More specialized care is needed to improve the clinical outcomes of diabetic CKD 5D patients.
引用
收藏
页码:20 / 32
页数:13
相关论文
共 50 条
  • [41] Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada
    Yeates, Karen
    Zhu, Naisu
    Vonesh, Edward
    Trpeski, Lilyanna
    Blake, Peter
    Fenton, Stanley
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (09) : 3568 - 3575
  • [42] Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives
    Scalise, Filippo
    Quarti-Trevano, Fosca
    Toscano, Evelina
    Sorropago, Antonio
    Vanoli, Jennifer
    Grassi, Guido
    HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION, 2024, 31 (01) : 7 - 13
  • [43] Patients with end-stage renal disease and diabetes had similar survival rates whether they received hemodialysis or peritoneal dialysis
    Xu, Feng
    Yang, Yue
    Wu, Man
    Zhou, Wenhua
    Wang, Dongxue
    Cui, Wenpeng
    THERAPEUTIC APHERESIS AND DIALYSIS, 2023, 27 (01) : 59 - 65
  • [44] Cardiac surgery in patients with end-stage renal disease on dialysis
    Back, Caroline
    Hornum, Mads
    Moller, Christian Joost Holdflod
    Olsen, Peter Skov
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2017, 51 (06) : 334 - 338
  • [45] Safety and Efficacy of Statins in Patients With End-Stage Renal Disease
    Nemerovski, Carrie W.
    Lekura, Jona
    Cefaretti, Michelle
    Mehta, Pooja T.
    Moore, Carol L.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1321 - 1329
  • [46] Is End-Stage Renal Disease Tumor Suppressive? Dispelling the Myths
    Migita, Toshiro
    CANCERS, 2024, 16 (18)
  • [47] Characteristics of Elderly Patients with Diabetes and End-Stage Renal Disease
    Goldfarb-Rumyantzev, Alexander S.
    Rout, Preeti
    SEMINARS IN DIALYSIS, 2010, 23 (02) : 185 - 190
  • [48] Chronic dialysis in patients with end-stage renal disease: Relevance to kidney xenotransplantation
    Jagdale, Abhijit
    Cooper, David K. C.
    Iwase, Hayato
    Gaston, Robert S.
    XENOTRANSPLANTATION, 2019, 26 (02)
  • [49] End-stage renal disease in leprosy
    Lomonte, C
    Chiarulli, G
    Cazzato, F
    Giammaria, B
    Marchio, G
    Losurdo, N
    Antonelli, M
    Casucci, F
    Basile, C
    JOURNAL OF NEPHROLOGY, 2004, 17 (02) : 302 - 305
  • [50] Pharmacotherapy of end-stage renal disease
    Schmid, Holger
    Schiffl, Helmut
    Lederer, Stephan R.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 597 - 613